Enfusion Inc. (ENFN)

AI Score

Unlock

10.76

-0.04 (-0.37%)

At close: Apr 17, 2025, 3:59 PM

10.61

-1.37%

After-hours: Apr 17, 2025, 08:00 PM EDT

Enfusion Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue	52.94M	51.17M	49.45M	48.05M	46.49M	44.36M	42.72M	40.97M	40.52M	39.15M	36.54M	34.14M	31.85M	29.05M	26.45M	24.35M	22.66M	19.79M	18.56M	18.56M
Cost of Revenue	16.4M	16.34M	15.96M	16.17M	15.62M	14.51M	14.21M	13.3M	13.3M	11.97M	10.85M	10.98M	10.16M	8.1M	6.78M	6.81M	6.16M	5.39M	4.9M	4.9M
Gross Profit	36.54M	34.83M	33.49M	31.88M	30.86M	29.85M	28.51M	27.67M	27.22M	27.18M	25.69M	23.16M	21.69M	20.95M	19.67M	17.54M	16.5M	14.39M	13.66M	13.66M
Operating Income	1.58M	2.98M	2.7M	-1.11M	2.13M	2.69M	2.45M	4.68M	1.37M	2.94M	-3.91M	-12.37M	-292.5M	4.9M	5.91M	5.8M	-11.92M	6.17M	5.91M	5.91M
Interest Income	533K	487K	356K	317K	1.64M	n/a	462K	492K	424K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	364K	364K
Pretax Income	2.46M	2.86M	2.95M	-878K	2.18M	3.03M	1.19M	5.09M	1.21M	2.88M	-3.91M	-12.37M	-294.02M	3.45M	4.5M	4.41M	-12.41M	5.81M	5.55M	5.55M
Net Income	121K	1.42M	1.83M	-539K	623K	1.83M	629K	4.69M	788K	2.6M	-2.42M	-12.52M	-293.89M	3.29M	4.25M	4.11M	-12.19M	5.58M	5.33M	5.33M
Selling & General & Admin	27.72M	25M	24.69M	26.44M	22.67M	22.22M	21.6M	18.56M	21.07M	20.37M	25.88M	30.73M	167.63M	13.45M	11.72M	9.54M	26.63M	6.58M	6.31M	6.31M
Research & Development	7.24M	6.84M	6.1M	6.55M	6.06M	4.94M	4.46M	4.43M	4.78M	3.86M	3.72M	4.8M	146.56M	2.6M	2.04M	2.2M	1.8M	1.64M	1.44M	1.44M
Other Expenses	n/a	n/a	-111K	-82K	-1.67M	417K	-1.26M	411K	-590K	-52K	1K	3K	-1.21M	29K	n/a	n/a	81K	n/a	n/a	n/a
Operating Expenses	34.96M	31.84M	30.79M	32.99M	28.73M	27.16M	26.07M	22.99M	25.85M	24.24M	29.6M	35.53M	314.19M	16.05M	13.76M	11.74M	28.42M	8.22M	7.74M	7.74M
Interest Expense	n/a	n/a	n/a	n/a	303K	n/a	n/a	1.34M	424K	4K	1K	6K	307K	1.49M	1.41M	1.39M	570K	365K	n/a	n/a
Selling & Marketing Expenses	6.57M	6.22M	6.02M	6.22M	5.55M	5.5M	5.28M	4.09M	6M	7.28M	7.58M	8.43M	39.4M	4.9M	4.26M	3.16M	3.31M	2.07M	2.27M	2.27M
Cost & Expenses	51.35M	48.19M	46.75M	49.16M	44.35M	41.67M	40.27M	36.29M	39.15M	36.21M	40.45M	46.51M	324.35M	24.14M	20.54M	18.55M	34.58M	13.61M	12.65M	12.65M
Income Tax Expense	2.34M	904K	401K	-117K	1.28M	367K	188K	396K	418K	287K	219K	150K	-125K	154K	249K	302K	-223K	228K	214.5K	214.5K
Shares Outstanding (Basic)	94.26M	92.9M	92.38M	89.51M	88.28M	87.74M	88.31M	88.86M	88.02M	131.76M	84.58M	79.81M	83.17M	64.07M	64.07M	64.07M	64.07M	64.07M	64.07M	88.56M
Shares Outstanding (Diluted)	129.56M	128.98M	128.85M	89.51M	127.77M	127.84M	129.86M	132.35M	132.95M	131.76M	84.58M	83.38M	83.17M	64.07M	64.07M	64.07M	64.07M	64.07M	64.07M	88.56M
EPS (Basic)	0.00	0.02	0.02	-0.01	0.01	0.02	0.01	0.05	0.01	0.02	-0.03	-0.16	-3.53	0.05	0.07	0.06	-0.19	0.09	0.08	0.06
EPS (Diluted)	0.00	0.02	0.01	-0.01	0.00	0.01	0.00	0.04	0.01	0.02	-0.03	-0.15	-3.53	0.05	0.07	0.06	-0.19	0.09	0.08	0.06
EBITDA	1.58M	5.82M	5.58M	1.56M	4.65M	2.69M	3.73M	4.68M	2.36M	4.64M	-2.29M	-11.03M	-292.4M	4.9M	6.83M	6.56M	-11.17M	6.61M	6.25M	6.25M
EBIT	1.58M	2.98M	2.7M	-1.11M	2.1M	3.03M	1.19M	5.09M	1.37M	2.94M	-3.91M	-12.37M	-293.71M	4.9M	5.91M	5.8M	-11.84M	6.17M	5.91M	5.91M
Depreciation & Amortization	n/a	2.96M	2.87M	2.67M	2.12M	4.5M	5.38M	1.83M	1.95M	1.7M	1.61M	1.34M	1.32M	987K	917K	755K	670K	1.26M	343K	343K